To date, 45 patients with 24 KCNH1 mutations have been reported with a phenotype characterized by a remarkable clinical heterogeneity, from mild to severe developmental delay and/or ID and epilepsy [27–39, 52]. This evidence concerns the gene KCNH1 and epilepsy.